Active, not recruitingNCT06106789
A Study of the Clinical Benefit of Tobramycin Inhalation Solution
Studying Idiopathic bronchiectasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Qianfoshan Hospital
- Principal Investigator
- Rui Yang, MDQianfoshan Hospital
- Intervention
- Tobramycin inhalation solution(drug)
- Enrollment
- 1600 enrolled
- Eligibility
- All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Rui Yang,MD, Jinan, Shandong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06106789 on ClinicalTrials.govOther trials for Idiopathic bronchiectasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07274631A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised MedicineCHU de Reims
- RECRUITINGNANCT06983366Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary DiseasesAssiut University
- ACTIVE NOT RECRUITINGNANCT06636487Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPDCopenhagen University Hospital, Hvidovre
- RECRUITINGPHASE2NCT06368804Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With BronchiectasisCentre Hospitalier Intercommunal Creteil
- ACTIVE NOT RECRUITINGNCT07490704Clinical Outcomes of BronchiEctaSis in Taiwan: A Multicenter Prospective Cohort (BEST Study)National Taiwan University Hospital
- RECRUITINGNCT05783869Study of Bronchiectasis and Associated Cardiovascular ComorbiditiesAssiut University
- RECRUITINGNCT06144996Development of a Canadian Bronchiectasis and NTM DatabaseUniversity of Calgary
- RECRUITINGNCT03120481Controls for Respiratory DiseasesSeoul National University Hospital